Salvage surgery after failed primary concomitant chemoradiation

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 2, 2008, Pages 135-140

  Lee, Steve C ^a   Shores, Carol G ^a   Weissler, Mark C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Chemoradiation; Salvage surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; FISTULA; HEAD AND NECK CANCER; HEART ATRIUM FIBRILLATION; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; NASOPHARYNX CANCER; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SKIN NECROSIS; WOUND COMPLICATION;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; POSTOPERATIVE COMPLICATIONS; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 40449133300     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282f495b6     Document Type: Review

References (46)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324:1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349:2091-2098.
3. Cmelak AJ, Li S, Goldwasser MA, et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 2007; 25:3971-3977.
4. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 2006; 24:593-598.
5. Foote RL, Foote RT, Brown PD, et al. Organ preservation for advanced laryngeal carcinoma. Head Neck 2006; 28:689-696.
6. Guadagnolo BA, Haddad RI, Posner MR, et al. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol 2005; 28:371-378.
7. Brockstein B, Vokes EE. Concurrent chemoradiotherapy for head and neck cancer. Semin Oncol 2004; 31:786-793.
8. Wolf GT, Bradford CR, Urba S, et al. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer. Laryngoscope 2002; 112:1351-1356.
9. Shirinian MH, Weber RS, Lippman SM, et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Head Neck 1994; 16:39-44.
10. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88:890-899.
11. Domenge C, Hill C, Lefebvre JL, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer 2000; 83:1594-1598.
12. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91:2081-2086.
13. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16:1310-1317.
14. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003; 21:631-637.
15. Browman GP, Hodson DI, Mackenzie RJ, et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 2001; 23:579-589.
16. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355:949-955.
17. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14:838-847.
18. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71:83-91.
19. Stell PM. Adjuvant Chemotherapy in Head and Neck Cancer. Semin Radiat Oncol 1992; 2:195-205.
20. Urba SG, Moon J, Giri PG, et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 2005; 23:88-95.
21. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 2007; 117:16-21. This is an interesting analysis of treatment trends in oropharyngeal cancer.
22. Chen AY, Schrag N, Hao Y, et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006; 135:831-837. This is another analysis by the group above, this time looking at laryngeal cancer.
23. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116:1-13. This paper provides in depth analysis of treatment trends and possible correlation with survival.
24. Adelstein DJ, Saxton JP, Rybicki LA, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006; 24:1064-1071.
25. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110:1-18.
26. Agra IM, Carvalho AL, Pontes E, et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg 2003; 129:1317-1321.
27. Weber RS, Berkey BA, Forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg 2003; 129:44-49.
28. Ganly I, Patel S, Matsuo J, et al. Postoperative complications of salvage total laryngectomy. Cancer 2005; 103:2073-2081.
29. Richey LM, Shores CG, George J, et al. The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Otolaryngol Head Neck Surg 2007; 136:98-103. This study represents the largest series on salvage surgery after concurrent CRT with biopsy-proven recurrence and provides probably the most accurate information on efficacy of salvage surgery in this patient population.
30. Morgan JE, Breau RL, Suen JY, et al. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2007; 133:10-14. This study reports on the morbidity of salvage surgery after CRT.
31. Withrow KP, Rosenthal EL, Gourin CG, et al. Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope 2007; 117:781-784. This study highlighted the effectiveness of free tissue transfer in reducing the local wound complications associated with salvage surgery.
32. Kim AJ, Suh JD, Sercarz JA, et al. Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope 2007; 117:1019-1023. This large series of 106 patients demonstrates the types of complications that can be expected with the advent of reconstruction with free flaps.
33. Agra IM, Carvalho AL, Ulbrich FS, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006; 28:107-113. This series of 96 patients highlights the relatively low success rate of salvage surgery in oropharynx and oral cavity.
34. Stoeckli SJ, Pawlik AB, Lipp M, et al. Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 2000; 126:1473-1477.
35. Gleich LL, Ryzenman J, Gluckman JL, et al. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg 2004; 130:35-38.
36. Ganly I, Patel SG, Matsuo J, et al. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg 2006; 132:59-66. This series of 43 patients demonstrates the effect of tumor stage on salvage surgery and also addresses the role of partial laryngectomy in salvage procedures.
37. Ahmed KA, Robbins KT, Wong F, et al. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 2000; 110:1789-1793.
38. Yom SS, Machtay M, Biel MA, et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 2005; 28:385-392.
39. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357:1705-1715.
40. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354:567-578.
41. Ishigami T, Uzawa K, Higo M, et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer 2007; 120:2262-2270.
42. Ogawa K, Murayama S, Mori M. Predicting the tumor response to radiotherapy using microarray analysis. Oncol Rep 2007; 18:1243-1248. This is an interesting review on microarray analysis of predictors of radiosensitivity.
43. Taussky D, Dulguerov P, Allal AS. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck 2005; 27:182-186.
44. Salaun PY, Abgral R, Querellou S, et al. Does (18)fluoro- fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Head Neck 2007; 29:1115-1120. The authors discuss specificity and sensitivity of PET scanning in surveillance of head and neck cancer.
45. de Bree R, van der Putten L, Hoekstra OS, et al. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy. Contemp Clin Trials 2007; 28:705-712.
46. Zbaren P, Nuyens M, Curschmann J, et al. Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas. Head Neck 2007; 29:26-32. This describes superb work on histologic differences between recurrent and primary tumors.